Mometasone furoate (Aspen Mometasone)
Mometasone furoate
Pharmacare limited û woodmead
Registration
- Applicant
- Pharmacare limited û woodmead
- Certificate holder
- Pharmacare limited
- Registrations
- 1
- Schedule source
- SAHPRA documentation
Variants
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Mometasone furoate
S4: Mometasone furoate
- except when intended for inhalation or nasal administration.
Consolidated Schedules 06 July 2026, line 7167
S3: Mometasone furoate
- when intended for inhalation or nasal administration, except when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
- a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
- a maximum pack size of 200 doses. (S2, S4)
Consolidated Schedules 06 July 2026, lines 3960 to 3965
S2: Mometasone furoate
- when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
- a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
- a maximum pack size of 200 doses. (S3, S4)
Consolidated Schedules 06 July 2026, lines 2284 to 2290
Pharmacological class: Corticosteroids with or without anti-infective agents. (class 13.4.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
Drag to rotate. Structure from PubChem CID 441336.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.